halofuginone has been researched along with Autoimmune Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dou, H; Duan, ZH; Wang, SQ; Zhao, YR | 1 |
| Baek, SY; Cho, ML; Kim, HY; Kim, SM; Kwok, SK; Lee, DG; Lee, J; Lim, MA; Park, EM; Park, JS; Park, MK; Park, SH; Woo, JW; Yang, EJ | 1 |
| Sule, SD; Wigley, FM | 1 |
2 review(s) available for halofuginone and Autoimmune Disease
| Article | Year |
|---|---|
[Advances in studies on autoimmune diseases treated by halofuginone].
Topics: Autoimmune Diseases; Humans; Medicine, Chinese Traditional; Piperidines; Quinazolinones | 2017 |
Novel therapy in the treatment of scleroderma.
Topics: Autoimmune Diseases; Bone Marrow Transplantation; Cysteine; Humans; Interferon-gamma; Nitric Oxide; Piperidines; Prostaglandins; Quinazolines; Quinazolinones; Relaxin; Scleroderma, Systemic; Tetracycline; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2001 |
1 other study(ies) available for halofuginone and Autoimmune Disease
| Article | Year |
|---|---|
Halofuginone ameliorates autoimmune arthritis in mice by regulating the balance between Th17 and Treg cells and inhibiting osteoclastogenesis.
Topics: Animals; Arthritis; Autoimmune Diseases; Cell Differentiation; Disease Models, Animal; Disease Progression; Forkhead Transcription Factors; Male; Mice; Mice, Inbred DBA; Mice, Knockout; NFATC Transcription Factors; Osteoclasts; Osteoprotegerin; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; Signal Transduction; STAT3 Transcription Factor; T-Lymphocytes, Regulatory; Th17 Cells | 2014 |